Abstract:CRISPR-Cas systems are widely used for genome engineering technologies, and in their natural setting, they play crucial roles in bacterial and archaeal adaptive immunity, protecting against phages and other mobile genetic elements. Previously we discovered bacteriophage-encoded Cas9-specific anti-CRISPR (Acr) proteins that serve as countermeasures against host bacterial immunity by inactivating their CRISPR-Cas systems 1 . We hypothesized that the evolutionary advantages conferred by anti-CRISPRs would drive the widespread occurrence of these proteins in nature 2–4 . We have identified new anti-CRISPRs using the bioinformatic approach that successfully identified previous Acr proteins 1 against Neisseria meningitidis Cas9 (NmeCas9). In this work we report two novel anti-CRISPR families in strains of Haemophilus parainfluenzae and Simonsiella muelleri , both of which harbor type II-C CRISPR-Cas systems 5 . We characterize the type II-C Cas9 orthologs from H. parainfluenzae and S. muelleri , show that the newly identified Acrs are able to inhibit these systems, and define important features of their inhibitory mechanisms. The S. muelleri Acr is the most potent NmeCas9 inhibitor identified to date. Although inhibition of NmeCas9 by anti-CRISPRs from H. parainfluenzae and S. muelleri reveals cross-species inhibitory activity, more distantly related type II-C Cas9s are not inhibited by these proteins. The specificities of anti-CRISPRs and divergent Cas9s appear to reflect co-evolution of their strategies to combat or evade each other. Finally, we validate these new anti-CRISPR proteins as potent off-switches for Cas9 genome engineering applications.

Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems

Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering

A comprehensive appraisal of mechanism of anti-CRISPR proteins: an advanced genome editor to amend the CRISPR gene editing

Computational design of anti-CRISPR proteins with improved inhibition potency and expanded specificity

Potent Cas9 inhibition in bacterial and human cells by new anti-CRISPR protein families

A Broad-Spectrum Inhibitor of CRISPR-Cas9

Structure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins

A Versatile Anti-CRISPR Platform for Opto- and Chemogenetic Control of CRISPR-Cas9 and Cas12 across a Wide Range of Orthologs

Diverse mechanisms of CRISPR-Cas9 inhibition by type II anti-CRISPR proteins

Anti-CRISPR AcrIIA5 Potently Inhibits All Cas9 Homologs Used for Genome Editing

Exploiting CRISPR/Cas: Interference Mechanisms and Applications

Disabling Cas9 by an anti-CRISPR DNA mimic

Broad-spectrum enzymatic inhibition of CRISPR-Cas12a

Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transfer

Structural and Mechanistic Insight into CRISPR-Cas9 Inhibition by Anti-CRISPR Protein AcrIIC4Hpa

Discovery of potent and versatile CRISPR-Cas9 inhibitors engineered for chemically controllable genome editing

De novo design of potent CRISPR-Cas13 inhibitors

The novel anti-CRISPR AcrIIA22 relieves DNA torsion in target plasmids and impairs SpyCas9 activity

Anti-CRISPR: discovery, mechanism and function

Structural insights into the inactivation of the type I-F CRISPR-Cas system by anti-CRISPR proteins